The prospective single-center study, published April 30 in the American Journal of Roentgenology, adds more weight to the growing literature suggesting PSMA-11’s vital role in prostate cancer management.


“Our findings show that radiotherapy is still highly effective in significantly improving local control and disease-free survival in combination with anti-hormones, compared to anti-hormones alone,” said Gerd Fastner, MD, during a presentation at the European Society for Radiotherapy and Oncology (ESTRO) 38 conference in Milan, Italy.

"There is an urgent need for more effective treatments for mesothelioma," said lead researcher Marco Trovo, MD, chief of the radiation oncology department at University Hospital of Udine in Italy.

Nearly all radiation oncologists agreed that prior authorization practices delay proper care for their cancer patients, according to a new survey of almost 700 specialists published by the American Society for Radiation Oncology (ASTRO).

"Our results suggest that lung cancer screening is substantially underutilized and not reaching high-risk smokers who would benefit the most," wrote Jinhai Huo, MD, PhD, in a new study published in Cancer Epidemiology, Biomarkers & Prevention.

"This study only answers the question about whether, in the first 12 months after diagnosis, costs of gene testing are likely to be offset by savings in avoided costs of chemotherapy—and the answer is yes," wrote authors of a new study published in JNCI.

Choosing a cancer treatment plan is not easy, and nearly a quarter of young adults diagnosed with the disease felt some regret about their initial treatment decision, according to a study reported on by Reuters.

The PET radiotracer 68Ga-PSMA-11 improved the detection of biochemically recurrent prostate cancer, according to results of a prospective trial published in JAMA Oncology.

International researchers have created a new ultrasound probe capable of delivering more precise treatment to women with gynecological cancers, reported authors of a feasibility study published in the Journal of Medical Imaging.

The American College of Physicians (ACP) now recommends women undergo mammography every other year, beginning at age 50. The new guidelines have drawn criticism from the American College of Radiology and Society of Breast Imaging.

In women 65 and older, digital breast tomosynthesis (DBT) achieved a higher specificity for detecting breast cancer and identified the disease at an earlier stage compared to traditional 2D mammography.

Whole-body PET/CT with the standard radiotracer 18F-FDG is a dependable screening tool for catching many metastases, distant as well as regional lymphatic, according to researchers at the University of Minnesota.